These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 33662286)

  • 1. Global costs, health benefits, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis.
    Ward ZJ; Scott AM; Hricak H; Atun R
    Lancet Oncol; 2021 Mar; 22(3):341-350. PubMed ID: 33662286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis.
    Ward ZJ; Atun R; Hricak H; Asante K; McGinty G; Sutton EJ; Norton L; Scott AM; Shulman LN
    Lancet Oncol; 2021 Sep; 22(9):1301-1311. PubMed ID: 34416159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysis.
    Ward ZJ; Scott AM; Hricak H; Abdel-Wahab M; Paez D; Lette MM; Vargas HA; Kingham TP; Atun R
    Lancet Oncol; 2020 Aug; 21(8):1077-1088. PubMed ID: 32758462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer incidence and survival for 11 cancers in the Commonwealth: a simulation-based modelling study.
    Ward ZJ; Gaba Q; Atun R
    Lancet Oncol; 2024 Sep; 25(9):1127-1134. PubMed ID: 39127064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysis.
    Ward ZJ; Grover S; Scott AM; Woo S; Salama DH; Jones EC; El-Diasty T; Pieters BR; Trimble EL; Vargas HA; Hricak H; Atun R
    Lancet Oncol; 2020 Aug; 21(8):1089-1098. PubMed ID: 32758463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding global access to radiotherapy.
    Atun R; Jaffray DA; Barton MB; Bray F; Baumann M; Vikram B; Hanna TP; Knaul FM; Lievens Y; Lui TY; Milosevic M; O'Sullivan B; Rodin DL; Rosenblatt E; Van Dyk J; Yap ML; Zubizarreta E; Gospodarowicz M
    Lancet Oncol; 2015 Sep; 16(10):1153-86. PubMed ID: 26419354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical imaging and nuclear medicine: a Lancet Oncology Commission.
    Hricak H; Abdel-Wahab M; Atun R; Lette MM; Paez D; Brink JA; Donoso-Bach L; Frija G; Hierath M; Holmberg O; Khong PL; Lewis JS; McGinty G; Oyen WJG; Shulman LN; Ward ZJ; Scott AM
    Lancet Oncol; 2021 Apr; 22(4):e136-e172. PubMed ID: 33676609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global childhood cancer survival estimates and priority-setting: a simulation-based analysis.
    Ward ZJ; Yeh JM; Bhakta N; Frazier AL; Girardi F; Atun R
    Lancet Oncol; 2019 Jul; 20(7):972-983. PubMed ID: 31129029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact.
    Rodin D; Burger EA; Atun R; Barton M; Gospodarowicz M; Grover S; Hanna TP; Jaffray DA; Knaul FM; Lievens Y; Zubizarreta E; Milosevic M
    Lancet Oncol; 2019 Jul; 20(7):915-923. PubMed ID: 31151906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guide posts for investment in primary health care and projected resource needs in 67 low-income and middle-income countries: a modelling study.
    Stenberg K; Hanssen O; Bertram M; Brindley C; Meshreky A; Barkley S; Tan-Torres Edejer T
    Lancet Glob Health; 2019 Nov; 7(11):e1500-e1510. PubMed ID: 31564629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustainable care for children with cancer: a Lancet Oncology Commission.
    Atun R; Bhakta N; Denburg A; Frazier AL; Friedrich P; Gupta S; Lam CG; Ward ZJ; Yeh JM; Allemani C; Coleman MP; Di Carlo V; Loucaides E; Fitchett E; Girardi F; Horton SE; Bray F; Steliarova-Foucher E; Sullivan R; Aitken JF; Banavali S; Binagwaho A; Alcasabas P; Antillon F; Arora RS; Barr RD; Bouffet E; Challinor J; Fuentes-Alabi S; Gross T; Hagander L; Hoffman RI; Herrera C; Kutluk T; Marcus KJ; Moreira C; Pritchard-Jones K; Ramirez O; Renner L; Robison LL; Shalkow J; Sung L; Yeoh A; Rodriguez-Galindo C
    Lancet Oncol; 2020 Apr; 21(4):e185-e224. PubMed ID: 32240612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing and cost of scaling up surgical services in low-income and middle-income countries from 2012 to 2030: a modelling study.
    Verguet S; Alkire BC; Bickler SW; Lauer JA; Uribe-Leitz T; Molina G; Weiser TG; Yamey G; Shrime MG
    Lancet Glob Health; 2015 Apr; 3 Suppl 2():S28-37. PubMed ID: 25926318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries.
    Schäferhoff M; Zimmerman A; Diab MM; Mao W; Chowdhary V; Gill D; Karanja R; Madikizela M; Ogbuoji O; Yamey G
    Lancet Glob Health; 2022 Jul; 10(7):e1045-e1052. PubMed ID: 35714631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050.
    Chen S; Cao Z; Prettner K; Kuhn M; Yang J; Jiao L; Wang Z; Li W; Geldsetzer P; Bärnighausen T; Bloom DE; Wang C
    JAMA Oncol; 2023 Apr; 9(4):465-472. PubMed ID: 36821107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resource needs for adolescent friendly health services: estimates for 74 low- and middle-income countries.
    Deogan C; Ferguson J; Stenberg K
    PLoS One; 2012; 7(12):e51420. PubMed ID: 23300548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global return on investment and cost-effectiveness of WHO's HEAR interventions for hearing loss: a modelling study.
    Tordrup D; Smith R; Kamenov K; Bertram MY; Green N; Chadha S;
    Lancet Glob Health; 2022 Jan; 10(1):e52-e62. PubMed ID: 34919856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic costs of childhood stunting to the private sector in low- and middle-income countries.
    Akseer N; Tasic H; Nnachebe Onah M; Wigle J; Rajakumar R; Sanchez-Hernandez D; Akuoku J; Black RE; Horta BL; Nwuneli N; Shine R; Wazny K; Japra N; Shekar M; Hoddinott J
    EClinicalMedicine; 2022 Mar; 45():101320. PubMed ID: 35308896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026.
    Global Burden of Disease 2021 Health Financing Collaborator Network
    Lancet Glob Health; 2023 Mar; 11(3):e385-e413. PubMed ID: 36706770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving a "Grand Convergence" in Global Health: Modeling the Technical Inputs, Costs, and Impacts from 2016 to 2030.
    Boyle CF; Levin C; Hatefi A; Madriz S; Santos N
    PLoS One; 2015; 10(10):e0140092. PubMed ID: 26452263
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.